Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.7700-0.3300 (-6.47%)
At close: 04:00PM EDT
4.8297 +0.06 (+1.25%)
After hours: 07:31PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
331,412
331,412
270,827
157,170
17,812
Cost of revenue
4,661
4,661
6,594
7,264
1,676
Gross profit
326,751
326,751
264,233
149,906
16,136
Operating expenses
Research development
216,566
216,566
253,297
208,808
122,964
Selling general and administrative
213,894
213,894
159,371
118,818
67,929
Total operating expenses
430,460
430,460
412,668
327,626
190,893
Operating income or loss
-103,709
-103,709
-148,435
-177,720
-174,757
Interest expense
108,239
108,239
99,092
59,294
14,501
Total other income/expenses net
-30,058
-30,058
-1,983
55,143
-2,976
Income before tax
-226,229
-226,229
-244,383
-181,809
-182,814
Income tax expense
310
310
2,733
2,253
0
Income from continuing operations
-226,539
-226,539
-247,116
-184,062
-182,814
Net income
-226,539
-226,539
-247,116
-184,062
-182,814
Net income available to common shareholders
-226,539
-226,539
-247,116
-184,062
-182,814
Basic EPS
-1.25
-
-1.33
-1.03
-1.09
Diluted EPS
-1.25
-
-1.33
-1.03
-1.09
Basic average shares
188,555
-
185,908
179,117
167,267
Diluted average shares
188,555
-
185,908
179,117
167,267